Response to Comments on "Pretreatment [⁶⁸Ga]-PSMA-11 PET/CT to Predict the Response to Treatment With Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors in Patients With Metastatic Renal Cell Carcinoma".
Saved in:
| Title: | Response to Comments on "Pretreatment [⁶⁸Ga]-PSMA-11 PET/CT to Predict the Response to Treatment With Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors in Patients With Metastatic Renal Cell Carcinoma". |
|---|---|
| Authors: | Chen SH; Department of Urology, Urology Research Institute, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Department of Urology, National Regional Medical Center, Binhai Campus, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Wu XH; Department of Urology, Urology Research Institute, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Department of Urology, National Regional Medical Center, Binhai Campus, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Qiu QR; Department of Urology, Urology Research Institute, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Department of Urology, National Regional Medical Center, Binhai Campus, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Chen SM; Department of Nuclear Medicine, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Department of Nuclear Medicine, National Regional Medical Center, Binhai Campus, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Zang J; Department of Nuclear Medicine, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Department of Nuclear Medicine, National Regional Medical Center, Binhai Campus, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Zhu JM; Department of Urology, Urology Research Institute, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Department of Urology, National Regional Medical Center, Binhai Campus, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Zeng CL; Department of Urology, Urology Research Institute, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Department of Urology, National Regional Medical Center, Binhai Campus, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Miao WB; Department of Nuclear Medicine, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Department of Nuclear Medicine, National Regional Medical Center, Binhai Campus, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Fujian Key Laboratory of Precision Medicine for Cancer, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Xue XY; Department of Urology, Urology Research Institute, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Department of Urology, National Regional Medical Center, Binhai Campus, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Fujian Key Laboratory of Precision Medicine for Cancer, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China. xuexueyi@fjmu.edu.cn., Xu N; Department of Urology, Urology Research Institute, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Department of Urology, National Regional Medical Center, Binhai Campus, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Fujian Key Laboratory of Precision Medicine for Cancer, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China. drxun@fjmu.edu.cn. |
| Source: | Korean journal of radiology [Korean J Radiol] 2026 Feb; Vol. 27 (2), pp. 188-190. Date of Electronic Publication: 2026 Jan 02. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Korean Society of Radiology Country of Publication: Korea (South) NLM ID: 100956096 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2005-8330 (Electronic) Linking ISSN: 12296929 NLM ISO Abbreviation: Korean J Radiol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41494789 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Response to Comments on "Pretreatment [⁶⁸Ga]-PSMA-11 PET/CT to Predict the Response to Treatment With Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors in Patients With Metastatic Renal Cell Carcinoma". – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chen+SH%22">Chen SH</searchLink>; Department of Urology, Urology Research Institute, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Department of Urology, National Regional Medical Center, Binhai Campus, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.<br /><searchLink fieldCode="AU" term="%22Wu+XH%22">Wu XH</searchLink>; Department of Urology, Urology Research Institute, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Department of Urology, National Regional Medical Center, Binhai Campus, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.<br /><searchLink fieldCode="AU" term="%22Qiu+QR%22">Qiu QR</searchLink>; Department of Urology, Urology Research Institute, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Department of Urology, National Regional Medical Center, Binhai Campus, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.<br /><searchLink fieldCode="AU" term="%22Chen+SM%22">Chen SM</searchLink>; Department of Nuclear Medicine, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Department of Nuclear Medicine, National Regional Medical Center, Binhai Campus, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.<br /><searchLink fieldCode="AU" term="%22Zang+J%22">Zang J</searchLink>; Department of Nuclear Medicine, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Department of Nuclear Medicine, National Regional Medical Center, Binhai Campus, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.<br /><searchLink fieldCode="AU" term="%22Zhu+JM%22">Zhu JM</searchLink>; Department of Urology, Urology Research Institute, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Department of Urology, National Regional Medical Center, Binhai Campus, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.<br /><searchLink fieldCode="AU" term="%22Zeng+CL%22">Zeng CL</searchLink>; Department of Urology, Urology Research Institute, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Department of Urology, National Regional Medical Center, Binhai Campus, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.<br /><searchLink fieldCode="AU" term="%22Miao+WB%22">Miao WB</searchLink>; Department of Nuclear Medicine, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Department of Nuclear Medicine, National Regional Medical Center, Binhai Campus, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Fujian Key Laboratory of Precision Medicine for Cancer, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.<br /><searchLink fieldCode="AU" term="%22Xue+XY%22">Xue XY</searchLink>; Department of Urology, Urology Research Institute, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Department of Urology, National Regional Medical Center, Binhai Campus, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Fujian Key Laboratory of Precision Medicine for Cancer, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China. xuexueyi@fjmu.edu.cn.<br /><searchLink fieldCode="AU" term="%22Xu+N%22">Xu N</searchLink>; Department of Urology, Urology Research Institute, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Department of Urology, National Regional Medical Center, Binhai Campus, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Fujian Key Laboratory of Precision Medicine for Cancer, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China. drxun@fjmu.edu.cn. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100956096%22">Korean journal of radiology</searchLink> [Korean J Radiol] 2026 Feb; Vol. 27 (2), pp. 188-190. <i>Date of Electronic Publication: </i>2026 Jan 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Korean+Society+of+Radiology%22">Korean Society of Radiology </searchLink><i>Country of Publication: </i>Korea (South) <i>NLM ID: </i>100956096 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2005-8330 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2212296929%22">12296929 </searchLink><i>NLM ISO Abbreviation: </i>Korean J Radiol <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41494789 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3348/kjr.2025.1800 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 188 Titles: – TitleFull: Response to Comments on "Pretreatment [⁶⁸Ga]-PSMA-11 PET/CT to Predict the Response to Treatment With Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors in Patients With Metastatic Renal Cell Carcinoma". Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chen SH – PersonEntity: Name: NameFull: Wu XH – PersonEntity: Name: NameFull: Qiu QR – PersonEntity: Name: NameFull: Chen SM – PersonEntity: Name: NameFull: Zang J – PersonEntity: Name: NameFull: Zhu JM – PersonEntity: Name: NameFull: Zeng CL – PersonEntity: Name: NameFull: Miao WB – PersonEntity: Name: NameFull: Xue XY – PersonEntity: Name: NameFull: Xu N IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2026 Feb Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2005-8330 Numbering: – Type: volume Value: 27 – Type: issue Value: 2 Titles: – TitleFull: Korean journal of radiology Type: main |
| ResultId | 1 |
